Commentary on NICE technology appraisal guidance on ezetimibe for the treatment of primary (heterozygous-familial and non-familial) hypercholesterolaemia.

Commentary on NICE technology appraisal guidance on ezetimibe for the treatment of primary (heterozygous-familial and non-familial) hypercholesterolaemia.

Bibliographic Details
Main Author:	Armitage, J
Format:	Journal article
Language:	English
Published:	2008

Similar Items

Controversies in familial hypercholesterolaemia: recommendations of the NICE Guideline Development Group for the identification and management of familial hypercholesterolaemia.
by: Minhas, R, et al.
Published: (2009)

Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia.
by: Neil, H, et al.
Published: (2004)

Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia
by: Neil, H, et al.
Published: (2003)

Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia
by: Neil, A, et al.
Published: (2003)

CTCA in children with severe heterozygous familial hypercholesterolaemia: Screening for subclinical atherosclerosis
by: M. Doortje Reijman, et al.
Published: (2024-03-01)

Commentary: What's so special about familial hypercholesterolaemia?
by: Mant, D
Published: (2009)

Ezetimibe for the treatment of hypercholesterolaemia: a systematic review and economic evaluation
by: R Ara, et al.
Published: (2008-05-01)

Familial hypercholesterolaemia.
by: Gill, P, et al.
Published: (2012)

Synopsis of an integrated guidance for enhancing the care of familial hypercholesterolaemia: an Australian perspective
by: Gerald F. Watts, et al.
Published: (2021-06-01)

Statin treatment for children and adolescents with heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis.
by: Arambepola, C, et al.
Published: (2007)

Statins and familial hypercholesterolaemia.
by: Neil, A, et al.
Published: (2009)

The impact of ezetimibe and high-dose of statin treatment on LDL levels in patients with heterozygous familial hypercholesterolemia.
by: Pitsavos, C, et al.
Published: (2009)

Commentary: Controversies in NICE guidance on chronic kidney disease.
by: Landray, M, et al.
Published: (2008)

Commentary: Controversies in NICE guidance on chronic kidney disease
by: Landray, M, et al.
Published: (2008)

Risk factors for cardiovascular events in patients with heterozygous familial hypercholesterolaemia: protocol for a systematic review
by: Jing Pang, et al.
Published: (2023-03-01)

Heterozygous familial hypercholesterolaemia in a pair of identical twins: a case report and updated review
by: Noor Shafina Mohd Nor, et al.
Published: (2019-04-01)

EASILY MISSED? Familial hypercholesterolaemia
by: Gill, P, et al.
Published: (2012)

Commentary: NICE guidance on antibiotic prescribing for self limiting respiratory tract infections in primary care
by: Butler, C, et al.
Published: (2008)

Cost-Effectiveness of Screening Algorithms for Familial Hypercholesterolaemia in Primary Care
by: Matthew Jones, et al.
Published: (2022-02-01)

Cost-effectiveness of evolocumab in treatment of heterozygous familial hypercholesterolaemia in Bulgaria: measuring health benefit by effectively treated patient-years*
by: Borislav Borissov, et al.
Published: (2017-01-01)

Familial Hypercholesterolaemia: An Updated Overall Management
by: Mohd Kasim, Noor Alicezah, et al.
Published: (2020)

Novel molecular therapies for the treatment of familial hypercholesterolaemia
by: Kerr, A
Published: (2016)

Family hypercholesterolaemia at children: clinic, diagnostics, treatment
by: D. I. Sadykova, et al.
Published: (2017-11-01)

Comparison of the risk of fatal coronary heart disease in treated xanthomatous and non-xanthomatous heterozygous familial hypercholesterolaemia: a prospective registry study.
by: Neil, H, et al.
Published: (2003)

Non-coronary heart disease mortality and risk of fatal cancer in patients with treated heterozygous familial hypercholesterolaemia: a prospective registry study.
by: Neil, H, et al.
Published: (2005)

The impact of rarity in NICE’s health technology appraisals
by: Sophie Clarke, et al.
Published: (2021-05-01)

Commentary: Controversies in NICE guidance on antibiotic prescribing for self limiting respiratory tract infections in primary care.
by: Butler, C, et al.
Published: (2008)

Systematic Identification of Familial Hypercholesterolaemia in Primary Care—A Systematic Review
by: Luisa Silva, et al.
Published: (2021-04-01)

Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
by: Vallejo-Vaz, Antonio J., et al.
Published: (2020)

International Atherosclerosis Society Roadmap for Familial Hypercholesterolaemia
by: Gerald F. Watts, et al.
Published: (2024-01-01)

Familial Hypercholesterolaemia as a Predisposing Factor for Atherosclerosis
by: Anastasia V. Poznyak, et al.
Published: (2022-10-01)

Dietary intervention for children and adolescents with familial hypercholesterolaemia
by: Maria Elena Capra, et al.
Published: (2023-06-01)

Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study
by: Neil, A, et al.
Published: (2008)

Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study.
by: Neil, A, et al.
Published: (2008)

Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group.
by: Neil, H, et al.
Published: (1999)

Low-density lipoprotein receptor-negative compound heterozygous familial hypercholesterolaemia: case study with follow-up over 23 years
by: C. van Heyningen, et al.
Published: (2022-10-01)

NICE and new: appraising innovation.
by: Ferner, R, et al.
Published: (2010)

Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia
by: Ian Hamilton-Craig, et al.
Published: (2010-11-01)

Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
by: Marks, D, et al.
Published: (2000)

Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
by: Marks, et al.
Published: (2000-01-01)